Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.76 |
| ▸ | RAB9A | P51151 | 1/20 | 0.76 |
| ▸ | FAAH | O00519 | 2/20 | 0.67 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.67 |
| ▸ | LHCGR | P22888 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10089405 | 1.00 | ALDH1A1 (0.76) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL1532563 | 0.87 | ALDH1A1 (1.00) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL21618461 | 0.87 | ALDH1A1 (1.00) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL8393776 | 0.87 | ALDH1A1 (1.00) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| Bicarbonate SCHEMBL15226094 | 0.85 | ALDH1A1 (0.97) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL5115600 | 0.85 | ALDH1A1 (0.97) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL9265423 | 0.84 | ALDH1A1 (0.88) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL1690686 | 0.84 | ALDH1A1 (0.82) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL8395644 | 0.82 | ALDH1A1 (0.90) | ALDH1A1RAB9AFAAHEPHX1LHCGR | |
| SCHEMBL8074322 | 0.81 | ALDH1A1 (0.76) | ALDH1A1RAB9AFAAHEPHX1LHCGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120010283-A1 | MODULATION OF ANXIETY THROUGH BLOCKADE OF ANANDAMIDE HYDROLYSIS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-01-12 | — | — | US | disclosed |
| US-8003693-B2 | Modulation of anxiety through blockade of anandamide hydrolysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-08-23 | — | — | US | disclosed |
| US-8003693-B2 | Modulation of anxiety through blockade of anandamide hydrolysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2011-08-23 | — | — | US | disclosed |
| US-20090048337-A1 | Modulation of anxiety through blockade of anandamide hydrolysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-02-19 | — | — | US | disclosed |
| US-20090048337-A1 | Modulation of anxiety through blockade of anandamide hydrolysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-02-19 | — | — | US | disclosed |
| US-7176201-B2 | Modulation of anxiety through blockade of anandamide hydrolysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-02-13 | — | — | US | disclosed |
| US-7176201-B2 | Modulation of anxiety through blockade of anandamide hydrolysis | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2007-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090048337-A1 | Modulation of anxiety through blockade of anandamide hydrolysis | FAAH, FAAH2, CNR2 | ALDH1A1 681/4885RAB9A 870/4885FAAH 1/4885 |
| US-20120010283-A1 | MODULATION OF ANXIETY THROUGH BLOCKADE OF ANANDAMIDE HYDROLYSIS | FAAH, FAAH2, CNR2 | ALDH1A1 734/4885RAB9A 944/4885FAAH 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.